Click for new scientific resources and news about Corona[COVID-19]

Paper Information

Journal:   ACTA MEDICA IRANICA   2004 , Volume 42 , Number 2; Page(s) 102 To 107.
 
Paper: 

STUDY OF CONCURRENT CISPLATIN AND EXTERNAL RADIOTHERAPY PRIOR TO RADICAL HYSTERECTOMY AND LYMPHADENECTOMY IN PATIENTS WITH STAGE IB-IIB CERVICAL CANCER

 
 
Author(s):  MODARES GILANI M., GOLNAVAZ M., AMOUZGAR HASHEMI F., GHANBARI Z.
 
* 
 
Abstract: 
The purpose of this study was to describe the feasibility of a combined preoperative
chemoradiation program Ib-IIa, bulky and suspicious IIb by radical surgery in patients with stage Ib-IIb cervical cancer. From September 1999 to April 2002, 30 patients with carcinoma of the cervix were treated with preoperative external beam radiotherapy of 45 Gy in 5 weeks. Patients received concurrent continuous infusion of cisplatin 50 mg/m2 for one day in week during 5 weeks of radiation. Radical surgery was performed 4-6 weeks after completion of the preoperative treatment. Toxicity with chemoradiation was usually mild. Two patients developed vesicovaginal fistula, and four developed long-term hydronephrosis that needed ureteral stenting. Clinical response was observed in 100% of the patients (23.7% complete response). The analysis of the surgical specimens revealed complete
pathological response in 43.3% of the cases and partial pathological response in 56.7%. The degree of pathological response was not predictable by the degree of clinical response. Thirty months disease-free survival and overall survival were 66.3% and 77.31%, respectively. Patients with complete and partial pathological response were not significantly different in terms of disease-free survival (p= 0.08) and overall survival (p= 0.3). Cisplatin in preoperative chemoradiation is effective and usually welltolerated in bulky cervical cancer and parametrial invasion, inducing a high rate of clinical and pathological complete responses. When this therapy is followed by radical surgery, disease-free and overall survival rates are higher. The latter may be possible only through extensive surgical resection with a parallel increase in complication rates.
 
Keyword(s): CERVICAL CANCER , CHEMORADIATION , RADICAL SURGERY
 
 
References: 
 
Citations: 
  • Not Registered.
 
+ Click to Cite.
APA: Copy

MODARES GILANI, M., & GOLNAVAZ, M., & AMOUZGAR HASHEMI, F., & GHANBARI, Z. (2004). STUDY OF CONCURRENT CISPLATIN AND EXTERNAL RADIOTHERAPY PRIOR TO RADICAL HYSTERECTOMY AND LYMPHADENECTOMY IN PATIENTS WITH STAGE IB-IIB CERVICAL CANCER. ACTA MEDICA IRANICA, 42(2), 102-107. https://www.sid.ir/en/journal/ViewPaper.aspx?id=13760



Vancouver: Copy

MODARES GILANI M., GOLNAVAZ M., AMOUZGAR HASHEMI F., GHANBARI Z.. STUDY OF CONCURRENT CISPLATIN AND EXTERNAL RADIOTHERAPY PRIOR TO RADICAL HYSTERECTOMY AND LYMPHADENECTOMY IN PATIENTS WITH STAGE IB-IIB CERVICAL CANCER. ACTA MEDICA IRANICA. 2004 [cited 2021June18];42(2):102-107. Available from: https://www.sid.ir/en/journal/ViewPaper.aspx?id=13760



IEEE: Copy

MODARES GILANI, M., GOLNAVAZ, M., AMOUZGAR HASHEMI, F., GHANBARI, Z., 2004. STUDY OF CONCURRENT CISPLATIN AND EXTERNAL RADIOTHERAPY PRIOR TO RADICAL HYSTERECTOMY AND LYMPHADENECTOMY IN PATIENTS WITH STAGE IB-IIB CERVICAL CANCER. ACTA MEDICA IRANICA, [online] 42(2), pp.102-107. Available: https://www.sid.ir/en/journal/ViewPaper.aspx?id=13760.



 
  pdf-File
Yearly Visit 35
 
 
Latest on Blog
Enter SID Blog